Hims & Hers Health Retained Earnings (Accumulated Deficit) 2020-2024 | HIMS

Hims & Hers Health retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Hims & Hers Health retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-0.268B, a 27.41% decline year-over-year.
  • Hims & Hers Health retained earnings (accumulated deficit) for 2023 were $-0.368B, a 6.83% increase from 2022.
  • Hims & Hers Health retained earnings (accumulated deficit) for 2022 were $-0.345B, a 23.54% increase from 2021.
  • Hims & Hers Health retained earnings (accumulated deficit) for 2021 were $-0.279B, a 62.85% increase from 2020.
Hims & Hers Health Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-368
2022 $-345
2021 $-279
2020 $-171
2019 $5
2018 $
Hims & Hers Health Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-268
2024-06-30 $-344
2024-03-31 $-357
2023-12-31 $-368
2023-09-30 $-369
2023-06-30 $-362
2023-03-31 $-355
2022-12-31 $-345
2022-09-30 $-334
2022-06-30 $-315
2022-03-31 $-295
2021-12-31 $-279
2021-09-30 $-248
2021-06-30 $-232
2021-03-31 $-223
2020-12-31 $-171
2020-09-30 $0
2020-06-30 $2
2020-03-31 $2
2019-12-31
2019-09-30 $0
2019-06-30 $-0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $8.842B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.872B 57.28
Tempus AI (TEM) United States $10.232B 0.00
Inspire Medical Systems (INSP) United States $5.430B 169.35
IRhythm Technologies (IRTC) United States $3.397B 0.00
Privia Health (PRVA) United States $2.723B 226.90
Enovis (ENOV) United States $2.544B 16.95
Azenta (AZTA) United States $2.469B 114.98
Clover Health Investments (CLOV) United States $2.225B 0.00
Schrodinger (SDGR) United States $1.886B 0.00
Omnicell (OMCL) United States $1.826B 39.83
10x Genomics (TXG) United States $1.773B 0.00
Phreesia (PHR) United States $1.680B 0.00
Butterfly Network (BFLY) United States $0.937B 0.00
Talkspace (TALK) United States $0.608B 0.00
Standard BioTools (LAB) United States $0.529B 0.00
Fulgent Genetics (FLGT) United States $0.507B 0.00
TruBridge (TBRG) United States $0.380B 110.57
Nyxoah SA (NYXH) Belgium $0.369B 0.00
Health Catalyst (HCAT) United States $0.334B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
American Well (AMWL) United States $0.176B 0.00
EUDA Health Holdings (EUDA) Singapore $0.104B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
P3 Health Partners (PIII) United States $0.073B 0.00
CareCloud (CCLD) United States $0.066B 0.00
HeartBeam (BEAT) United States $0.065B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
Outset Medical (OM) United States $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.043B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
MSP Recovery (MSPR) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00